Search Results - "Sequeira, Rafael"

A Multicenter, Randomized, Double-blind, Placebo-controlled Study of Tolvaptan Monotherapy Compared to Furosemide and the Combination of Tolvaptan and Furosemide in Patients With Heart Failure and Systolic Dysfunction by Udelson, James E., MD, Bilsker, Martin, MD, Hauptman, Paul J., MD, Sequeira, Rafael, MD, Thomas, Ignatius, MD, O’Brien, Terrence, MD, Zimmer, Christopher, MD, Orlandi, Cesare, MD, Konstam, Marvin A., MD

“…Abstract Background Increased vasopressin levels may be present in patient with chronic heart failure (HF) and contribute to pathophysiology through effects on…”
Get full text

Naked plasmid DNA encoding fibroblast growth factor type 1 for the treatment of end-stage unreconstructible lower extremity ischemia: Preliminary results of a phase I trial by Comerota, Anthony J., Throm, Richard C., Miller, Kathryn A., Henry, Timothy, Chronos, Nicolas, Laird, John, Sequeira, Rafael, Kent, Craig K., Bacchetta, Matthew, Goldman, Corey, Salenius, Juha-Pekka, Schmieder, Frank A., Pilsudski, Richard

“…Objective: The objective of this study was to evaluate the safety and tolerance of increasing single and repeated (n = 2) doses of intramuscular naked plasmid…”
Get full text

TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: Results of the TIMI 10B trial by CANNON, C. P, GIBSON, C. M, STEINGART, R. M, WEAVER, W. D, DE WERF, F. V, BRAUNWALD, E, MCCABE, C. H, ADGEY, A. A. J, SCHWEIGER, M. J, SEQUEIRA, R. F, GROLLIER, G, GIUGLIANO, R. P, FREY, M, MUELLER, H. S

“…Background —Bolus thrombolytic therapy is a simplified means of administering thrombolysis that facilitates rapid time to treatment. TNK-tissue plasminogen…”
Get full text

Pseudo‐Pulmonic Stenosis in Non‐Hodgkin's Large B‐cell Lymphoma by Badheka, Apurva, Marzouka, George R., Patel, Nileshkumar J., Esterson, Joseph, Sequeira, Rafael F.

“…There have only been a few cases reported of right ventricular outflow tract obstruction secondary to diffuse large B‐cell lymphomas. Mediastinal masses rarely…”
Get full text

Coronary Vasospasm While Treating Supraventricular Tachycardia : Is Adenosine Really to Blame? by Quevedo, Henry C., Munoz-Mendoza, Jerson, Pinto Miranda, Veronica, Sequeira, Rafael F.

“…Coronary artery spasm has been reported during adenosine stress testing. Herein, we describe a transient ST-segment elevation following adenosine therapy for…”
Get full text

TNK-tissue plasminogen activator in acute myocardial infarction : Results of the thrombolysis in myocardial infarction (TIMI) 10A dose-ranging trial by CANNON, C. P, MCCABE, C. H, LOVE, T. W, BRAUNWALD, E, GIBSON, C. M, GHALI, M, SEQUEIRA, R. F, MCKENDALL, G. R, BREED, J, MODI, N. B, FOX, N. L, TRACY, R. P

“…TNK-tissue plasminogen activator (TNK-TPA) is a genetically engineered variant of TPA, which in experimental models has a slower plasma clearance and greater…”
Get full text

Rescue angioplasty in the thrombolysis in myocardial infarction (TIMI) 4 trial by Gibson, C.Michael, Cannon, Christopher P., Greene, Robert M., Sequeira, Rafael F., Margorien, Raymond D., Leya, Ferdinand, Diver, Daniel J., Baim, Donald S., Braunwald, Eugene

“…Rescue percutaneous transluminal coronary angioplasty (PTCA) has been used to establish reperfusion after failed thrombolysis, and the goal of this study was…”
Get full text

Vasopeptidase inhibition with omapatrilat in chronic heart failure: acute and long-term hemodynamic and neurohumoral effects by McClean, Dougal R, Ikram, Hamid, Mehta, Sukh, Heywood, J.Thomas, Rousseau, Michel F, Niederman, Alan L, Sequeira, Rafael F, Fleck, Eckart, Singh, Steven N, Coutu, Benoit, Hanrath, Peter, Komajda, Michel, Bryson, Catherine C, Qian, Chunlin, Hanyok, James J

“…We investigated the acute and long-term hemodynamic and neurohumoral effects of the vasopeptidase inhibitor omapatrilat in human heart failure…”
Get full text

Determinants of coronary blood flow after thrombolytic administration by Gibson, C.Michael, Murphy, Sabina, Menown, Ian B.A., Sequeira, Rafael F., Greene, Robert, Van de Werf, Frans, Schweiger, Marc J., Ghali, Magdi, Frey, Martin J., Ryan, Kathryn A., Marble, Susan J., Giugliano, Robert P., Antman, Elliott M., Cannon, Christopher P., Braunwald, Eugene

“…OBJECTIVES This study evaluated the determinants of coronary blood flow following thrombolytic administration in a large cohort of patients. BACKGROUND Tighter…”
Get full text

Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial by Gibson, C.Michael, Cannon, Christopher P, Murphy, Sabina A, Adgey, A.A.Jennifer, Schweiger, Marc J, Sequeira, Rafael F, Grollier, Gilles, Fox, Norma Lynn, Berioli, Silvano, Weaver, W.Douglas, Van de Werf, Frans, Braunwald, Eugene

“…Fixed doses of thrombolytic agents are generally administered to patients of varying body weights, and the dose-response relation may be confounded by the…”
Get full text

Transdermal nitroglycerin patch therapy improves left ventricular function and prevents remodeling after acute myocardial infarction: Results of a multicenter prospective randomized, double-blind, placebo-controlled trial by MAHMARIAN, J. J, MOYE, L. A, PRATT, C. M, CHINOY, D. A, SEQUEIRA, R. F, HABIB, G. B, HENRY, W. J, JAIN, A, CHAITMAN, B. R, WENG, C. S. W, MORALES-BALLEJO, H

“…Nitrates are widely used in the treatment of angina in patients with acute myocardial infarction (AMI). Short-term administration prevents left ventricular…”
Get full text

Prospective Validation of a Composite End Point in Thrombolytic Trials of Acute Myocardial Infarction (TIMI 4 and 5) by Cannon, Christopher P., Sharis, Peter J., Schweiger, Marc J., McCabe, Carolyn H., Diver, Daniel J., Shah, Prediman K., Sequeira, Rafael F., Greene, Robert M., Perritt, Rebecca L., Poole, W.Kenneth, Braunwald, Eugene

“…Although the use of composite end points in clinical trials has increased in recent years, few data are available on the validity of such an approach. In the…”
Get full text

Heart rate variability during the first 24 hours of successfully reperfused acute myocardial infarction: Paradoxic decrease after reperfusion by Chakko, Simon, Fernandez, Aland, Sequeira, Rafael, Kessler, Kenneth M., Myerburg, Robert J.

“…Heart rate variability (HRV) was evaluated during the first 24 hours of hospitalization in 36 patients with acute myocardial infarction. Reperfusion was…”
Get full text

Relatório de Estágio Pedagógico Escola Secundária Afonso de Albuquerque: As Aulas de Educação Física em Regime Online: Os Efeitos De Um Programa De Treino Concorrente em Alunos do Sexo Feminino Pertencentes ao 10º ano de Escolaridade by Alves, Bruno Rafael Sequeira

“…O relatório de estágio foi realizado no âmbito do Mestrado de Educação Física dos Ensinos Básico e Secundário. O estágio foi realizado no ano letivo 2020/2021…”
Get full text

Money Never Sleeps – Overnight Returns in Equity Markets by de Almeida Sequeira, Rafael

“…The present research analyses overnight returns’ outperformance in relation to daytime returns. In a first stage, it will be assessed whether these returns are…”
Get full text

Prediction of medical morbidity and mortality after acute myocardial infarction in patients at increased psychosocial risk in the Enhancing Recovery in Coronary Heart Disease Patients (ENRICHD) study by Jaffe, Allan S., Krumholz, Harlan M., Catellier, Diane J., Freedland, Kenneth E., Bittner, Vera, Blumenthal, James A., Calvin, James E., Norman, James, Sequeira, Rafael, O'Connor, Christopher, Rich, Michael W., Sheps, David, Wu, Colin

“…Patients with myocardial infarction (MI) are at further increased risk for untoward events when patients also exhibit low social support and/or depression. The…”
Get full text

The electrocardiogram read as nonspecific ST-T waves by Sequeira, Rafael F., Lemberg, Louis

Get full text

Detection of thrombosed aortic Björk-Shiley valve by two-dimensional echocardiography by Kinney, E L, Schrager, B, Sequeira, R F, Machado, H, Chahine, R A

Get more information

Detection of posterior mediastinal lymphoma by pulsed Doppler echocardiography by Kinney, E L, Cotler, R P, Sequeira, R F, Thurer, R J, Saldana, M J, Chahine, R A

Get more information

861-3 A phase I open-label dose escalation trial of a monoclonal antibody against tissue factor (sunol cH36) in stable coronary artery disease: Results of the PROXIMATE-TIMI 27 trial by Morrow, David A, Sequeira, Rafael F, Henry, Tim D, Galitz, Lawrence A, Cooper, Howard A, Scirica, Benjamin M, Wong, Graham C, Wong, Hing C, McCabe, Carolyn H, Antman, Elliott M

Get full text